International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(20), P. 11187 - 11187
Published: Oct. 17, 2024
With
the
increasing
prevalence
and
serious
health
consequences
of
metabolic-associated
fatty
liver
disease
(MAFLD),
early
diagnosis
intervention
are
key
to
effective
treatment.
Recent
studies
highlight
important
role
dietary
factors,
including
use
flavonoids,
in
improving
health.
These
compounds
possess
anti-inflammatory,
antioxidant,
liver-protective
properties.
Flavonoids
have
been
shown
affect
gut
microbiota,
which
plays
a
function
progression.
Therefore,
their
preventing
development
progression
MAFLD
through
modulation
microbiome
seems
be
interest.
This
narrative
review
aims
consolidate
current
evidence
on
effects
selected
flavonoids
progression,
potential
mechanisms
action,
implications
for
personalized
interventions
management
disease.
Nutrition and Diabetes,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: May 22, 2024
Abstract
Aim
To
examine
the
associations
of
a
diet
high
in
flavonoid-rich
foods,
as
reflected
by
“Flavodiet
Score”
(FDS),
major
individual
food
contributors
to
flavonoid
intake,
and
subclasses
with
type
2
diabetes
(T2D)
risk
UK
Biobank
cohort.
Materials
methods
Flavonoid
intakes
were
estimated
from
≥2
dietary
assessments
among
113,097
study
participants
[age
at
enrolment:
56
±
8
years;
57%
female]
using
U.S
Department
Agriculture
(USDA)
databases.
Multivariable
Cox
proportional
hazards
models
used
investigate
between
exposures
T2D.
Results
During
12
years
follow-up,
2628
incident
cases
T2D
identified.
A
higher
FDS
(compared
lower
[Q4
vs.
Q1]),
characterised
an
average
6
servings
foods
per
day,
was
associated
26%
[HR:
0.74
(95%
CI:
0.66–0.84),
p
trend
=
<0.001].
Mediation
analyses
showed
that
body
fatness
basal
inflammation,
well
better
kidney
liver
function
partially
explain
this
association.
In
food-based
analyses,
black
or
green
tea,
berries,
apples
significantly
21%,
15%,
12%
risk.
Among
subclasses,
19–28%
risks
observed
those
highest,
compared
lowest
intakes.
Conclusions
consumption
risk,
potentially
mediated
benefits
obesity/sugar
metabolism,
function.
Achievable
increases
specific
have
potential
reduce
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(3), P. 564 - 564
Published: Jan. 31, 2025
Background:
Insufficient
treatment
options
are
available
for
metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD).
Flavonoids
and
topiramate
have
been
studied
weight
loss
but
need
investigation
into
their
effects
on
metabolism.
This
study’s
aim
was
to
examine
the
of
flavonoids
or
glucose
carbon
flux
in
a
cell
culture
model
steatosis.
Methods:
Steatosis
induced
HepG2
cells
through
exposure
oleic
acid
(OA,
0.5
mml/L)
conjugated
bovine
serum
albumin
(2:1).
Additionally,
50%
U13C-glucose
supplied
medium
as
stable
isotope
tracer.
Cells
were
treated
with
DMSO,
10
μM
naringenin,
morin,
silibinin,
(44
μM)
72
h.
A
non-steatotic,
untreated
control
included.
Cell
extracts
analyzed
by
gas
chromatography/mass
spectrometry
mass
isotopomer
distribution
analysis
glycogen
synthesis,
de
novo
fatty
tricarboxylic
(TCA)
cycle
activity,
ribose
synthesis.
Groups
compared
ANOVA
Tukey’s
pair-wise
testing.
Results:
Compared
controls,
OA-exposed
exhibited
increased
lipid
accumulation
ORO
staining
(1.6-fold),
enhanced
palmitate
reduced
pyruvate
carboxylase/pyruvate
dehydrogenase
(PC/PDH)
ratio,
Treatment
silibinin
ameliorated
(1.3-fold)
mitigated
enhancement
Morin-treated
synthesis
suppressed
Conclusions:
Potential
mechanisms
may
include
suppression
relative
decrease
PDH
pathway.
Further
studies
needed
potential
utility
MASLD
based
specific
effects.
Antioxidants,
Journal Year:
2023,
Volume and Issue:
12(11), P. 1928 - 1928
Published: Oct. 29, 2023
Chronic
liver
disease
(CLD)
affects
a
significant
portion
of
the
global
population,
leading
to
substantial
number
deaths
each
year.
Distinct
forms
like
non-alcoholic
fatty
(NAFLD)
and
alcoholic
(ALD),
though
they
have
different
etiologies,
highlight
shared
pathologies
rooted
in
oxidative
stress.
Central
metabolism,
mitochondria
are
essential
for
ATP
production,
gluconeogenesis,
acid
oxidation,
heme
synthesis.
However,
diseases
NAFLD,
ALD,
fibrosis,
mitochondrial
function
is
compromised
by
inflammatory
cytokines,
hepatotoxins,
metabolic
irregularities.
This
dysfunction,
especially
electron
leakage,
exacerbates
production
reactive
oxygen
species
(ROS),
augmenting
damage.
Amidst
this,
nuclear
factor
erythroid
2-related
2
(NRF2)
emerges
as
cellular
protector.
It
not
only
counters
stress
regulating
antioxidant
genes
but
also
maintains
health
overseeing
autophagy
biogenesis.
The
synergy
between
NRF2
modulation
introduces
new
therapeutic
potentials
CLD,
focusing
on
preserving
integrity
against
threats.
review
delves
into
intricate
role
shedding
light
innovative
strategies
its
prevention
treatment,
through
pathways.
Phytotherapy Research,
Journal Year:
2024,
Volume and Issue:
38(6), P. 3122 - 3145
Published: April 12, 2024
Abstract
Liver
fibrosis
is
a
dynamic
pathological
process
that
can
be
triggered
by
any
chronic
liver
injury.
If
left
unaddressed,
it
will
inevitably
progress
to
the
severe
outcomes
of
cirrhosis
or
even
hepatocellular
carcinoma.
In
past
few
years,
prevalence
and
fatality
hepatic
have
been
steadily
rising
on
global
scale.
As
result
its
intricate
pathogenesis,
quest
for
pharmacological
interventions
targeting
has
remained
formidable
challenge.
Currently,
no
pharmaceuticals
are
exhibiting
substantial
clinical
efficacy
in
management
fibrosis.
Hence,
utmost
importance
expedite
development
novel
therapeutics
treatment
this
condition.
Various
research
studies
revealed
ability
different
natural
flavonoid
compounds
alleviate
reverse
through
range
mechanisms,
which
related
regulation
inflammation,
oxidative
stress,
synthesis
secretion
fibrosis‐related
factors,
stellate
cells
activation,
proliferation,
extracellular
matrix
degradation
these
compounds.
This
review
summarizes
sources
flavonoids
with
inhibitory
effects
over
last
decades.
The
anti‐fibrotic
increasingly
studied,
making
them
potential
source
drugs
due
their
good
biosafety.
Frontiers in Nutrition,
Journal Year:
2024,
Volume and Issue:
11
Published: June 21, 2024
This
systematic
review
and
meta-analysis
of
clinical
observational
studies
aims
to
clarify
the
correlation
between
intake
levels
fruits
vegetables
non-alcoholic
fatty
liver
disease
(NAFLD).
Frontiers in Microbiology,
Journal Year:
2024,
Volume and Issue:
15
Published: April 4, 2024
Non-alcoholic
fatty
liver
disease
(NAFLD)
is
increasingly
recognized
for
its
global
prevalence
and
potential
progression
to
more
severe
diseases
such
as
non-alcoholic
steatohepatitis
(NASH).
The
gut
microbiota
plays
a
pivotal
role
in
the
pathogenesis
of
NAFLD,
yet
detailed
characteristics
ecological
alterations
microbial
communities
during
from
(NAFL)
NASH
remain
poorly
understood.
Methods:
In
this
study,
we
conducted
comparative
analysis
composition
individuals
with
NAFL
elucidate
differences
characteristics.
We
utilized
16S
rRNA
sequencing
compare
intestinal
among
healthy
control
group
(65
cases),
(64
(53
cases).
Random
forest
machine
learning
database
validation
methods
were
employed
analyze
data.
Results:
Our
findings
indicate
significant
decrease
diversity
flora
NAFLD
(
p
<
0.05).
At
phylum
level,
high
abundances
Bacteroidetes
Fusobacteria
observed
both
patients,
whereas
Firmicutes
less
abundant.
genus
Prevotella
expression
was
seen
(AUC
0.738),
an
increase
combination
Megamonas
Fusobacterium
noted
0.769).
Furthermore,
KEGG
pathway
highlighted
disturbances
various
types
glucose
metabolism
pathways
compared
group,
well
notably
compromised
flavonoid
flavonol
biosynthesis
functions.
study
uncovers
distinct
microecological
changes
within
transition
NASH,
providing
insights
that
could
facilitate
discovery
novel
biomarkers
therapeutic
targets
NAFLD.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: June 12, 2023
Abstract
Understanding
the
genetic
basis
of
biological
aging
in
multi-organ
systems
is
vital
for
elucidating
age-related
disease
mechanisms
and
identifying
therapeutic
interventions.
This
study
characterized
architecture
age
gap
(BAG)
across
nine
human
organ
377,028
individuals
European
ancestry
from
UK
Biobank.
We
discovered
393
genomic
loci-BAG
pairs
(P-value<5×10
-8
)
linked
to
brain,
eye,
cardiovascular,
hepatic,
immune,
metabolic,
musculoskeletal,
pulmonary,
renal
systems.
observed
BAG-organ
specificity
inter-organ
connections.
Genetic
variants
associated
with
BAGs
are
predominantly
specific
respective
system
while
exerting
pleiotropic
effects
on
traits
multiple
A
gene-drug-disease
network
confirmed
involvement
metabolic
BAG-associated
genes
drugs
targeting
various
disorders.
correlation
analyses
supported
Cheverud’s
Conjecture
1
–
between
mirrors
their
phenotypic
correlation.
causal
revealed
potential
linking
chronic
diseases
(e.g.,
Alzheimer’s
disease),
body
weight,
sleep
duration
BAG
Our
findings
shed
light
promising
interventions
enhance
health
within
a
complex
network,
including
lifestyle
modifications
drug
repositioning
strategies
treating
diseases.
All
results
publicly
available
at
https://labs-laboratory.com/medicine
.
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(2), P. 205 - 205
Published: Jan. 7, 2025
Evidence
regarding
the
individual
and
combined
impact
of
dietary
flavonoids
on
risk
metabolic
dysfunction
associated
with
steatotic
liver
disease
(MASLD)
remains
scarce.
Our
objective
is
to
evaluate
association
between
multiple
MASLD
in
adults.
Data
sets
were
obtained
from
National
Health
Nutrition
Examination
Survey
(NHANES),
2017-2018.
In
total,
2581
participants
aged
over
18
years,
complete
information
flavonoid
intake,
MASLD,
covariates,
included.
Flavonoid
intake
was
energy-adjusted
using
residual
method.
Logistic
regression
analysis
employed
examine
total
MASLD.
Weighted
quantile
sum
(WQS)
analyses
used
effects
identify
predominant
types
most
significant
contribution
prevention.
The
highest
tertile
a
29%
reduction
compared
lowest
after
multivariable
adjustments
(OR:
0.71,
95%
CI:
0.51-0.97).
WQS
revealed
that
anthocyanidins,
flavones,
flavanones
critical
contributors
among
six
subclasses
(weights
=
0.317,
0.279,
0.227,
respectively)
naringenin,
apigenin,
delphinidin
29
monomers.
0.240,
0.231,
0.114,
respectively).
Also,
higher
linked
reduced
(p
<
0.05).
findings
suggested
lower
flavanones,
delphinidin,
myricetin
contributing
protective
flavonoids.